Who makes PF-07799544?

PF-07799544 is developed by Pfizer Inc..

What development phase is PF-07799544 in?

PF-07799544 is FDA-approved (marketed).

What is the generic name of PF-07799544?

pf-07799544 is the generic (nonproprietary) name of PF-07799544.

Last reviewed 2026-04-20 · How we verify

PF-07799544 (pf-07799544)

Pfizer Inc. · FDA-approved active Quality 3/100

At a glance

Generic name	pf-07799544
Sponsor	Pfizer Inc.
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PF-07799544 CI brief — competitive landscape report
PF-07799544 updates RSS · CI watch RSS
Pfizer Inc. portfolio CI